Central nervous system complications during pediatric extracorporeal life support: incidence and risk factors

Pelin Cengiz1, Kristy Seidel, Peter T Rycus

  • 1Department of Pediatrics, University of Washington, Seattle, USA.

Critical Care Medicine
|December 15, 2005
PubMed

Insights

Pediatric patients requiring extracorporeal life support (ECLS) face a significant risk of central nervous system (CNS) complications. Pre-existing conditions like metabolic acidosis and use of certain devices increase this risk, necessitating close monitoring.

Area of Science:

  • Pediatric Critical Care Medicine
  • Cardiovascular Surgery
  • Neurology

Background:

  • Acute, severe central nervous system (CNS) complications are a serious concern in pediatric patients undergoing extracorporeal life support (ECLS).
  • Understanding the incidence and risk factors is crucial for improving patient outcomes.

Purpose of the Study:

  • To identify the incidence of acute, severe CNS complications in pediatric patients receiving ECLS.
  • To determine the risk factors associated with the development of these CNS complications.

Main Methods:

  • Retrospective review of the Extracorporeal Life Support Organization (ELSO) registry database.
  • Analysis of data from 4,942 pediatric patients (1 month to 18 years) treated between 1981-2002 across 115 international tertiary centers.

Main Results:

  • 12.9% of patients (636/4,942) developed acute, severe CNS complications.
  • Risk factors identified include: ECLS during extracorporeal cardiopulmonary resuscitation (OR 2.48), pre-ECLS left ventricular assist device use (OR 3.45), bicarbonate administration (OR 1.61), and vasopressor/inotropic medications (OR 1.22).
  • Venoarterial ECLS for pulmonary failure was associated with higher CNS complication rates compared to venovenous ECLS (13.5% vs 5.7%).

Conclusions:

  • Patients with pre-ECLS metabolic acidosis, requirement for bicarbonate or inotropes/vasopressors, cardiopulmonary resuscitation, or a left ventricular assist device are at increased risk.
  • Close monitoring for CNS complications is recommended for patients developing renal failure or metabolic acidosis post-ECLS, or those undergoing venoarterial ECLS.
Abstract

Related Concept Videos

Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
Increased Intracranial Pressure l: Introduction01:14

Increased Intracranial Pressure l: Introduction

Intracranial hypertension is a sustained elevation of intracranial pressure (ICP) above 22 mm Hg. In supine adults, normal ICP is ~7–15 mm Hg.The rigid, nonexpandable cranium contains three components—brain tissue, blood, and cerebrospinal fluid (CSF)—that total ~1,700 mL in a typical adult: 1,400 mL brain (~80%), 150 mL blood (~10%), and 150 mL CSF (~10%). According to the Monro–Kellie doctrine, total intracranial volume is effectively fixed. When one component expands, CSF and venous blood...
Increased Intracranial Pressure ll: Pathophysiology01:29

Increased Intracranial Pressure ll: Pathophysiology

Increased intracranial pressure (ICP) refers to a potentially life-threatening rise in pressure inside the skull. This usually happens when there is a major change in the volume of brain tissue, blood, or cerebrospinal fluid (CSF) — the three components inside the skull. According to the Monro-Kellie doctrine, if the volume of one component increases, the volumes of the other components must decrease to maintain normal pressure. If this does not happen, ICP rises.The process often begins with...
Cytotoxic Edema: Pathophysiology01:21

Cytotoxic Edema: Pathophysiology

Cytotoxic edema is a form of cerebral edema characterized by intracellular swelling of neurons, astrocytes, and other glial cells. It develops when the mechanisms responsible for maintaining ionic gradients across the cell membrane become impaired. Under normal physiological conditions, the sodium–potassium ATPase actively transports sodium ions out of the cell and potassium ions into the cell, preserving osmotic balance and enabling electrical signaling. This pump requires a continuous supply...
Secondary Spinal Cord Injury llI: Pathophysiology01:25

Secondary Spinal Cord Injury llI: Pathophysiology

Early Ischemia and Ionic ImbalanceWithin minutes of spinal cord injury, a secondary cascade begins, progressing over hours to weeks. Vascular damage reduces blood flow, causing ischemia and mitochondrial dysfunction. ATP depletion leads to ion pump failure, membrane depolarization, sodium influx, potassium efflux, and water accumulation, resulting in cellular swelling. Increased intracellular calcium further disrupts mitochondria and accelerates cellular injury.Excitotoxicity and Neuronal...